Las Vegas, NV -- (SBWIRE) -- 11/01/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Tower Group International, Ltd. (NASDAQ:TWGP), Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Galena Biopharma Inc (NASDAQ:GALE), Andalay Solar Inc (OTCMKTS: WEST)
Tower Group International, Ltd. (NASDAQ:TWGP) managed to keep its fall at -3.32% on below -normal volume of 1.76M shares. The stock settled at $3.63 after floating in a range of $3.54 to $3.62. Its latest price has reached market capitalization of $215.94 million. Its 52-week range has been $3.54 to $22.30. Tower Group International, Ltd., through its subsidiaries, underwrites insurance and reinsurance products in Bermuda, the United States, and London markets.
Has TWGP Found The Bottom and Ready To Move Up? Find Out Here
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) traded down on a volume of 1.70 million, higher than its standard daily volume. Shares have dropped-2.19% to $2.68. Over the last twelve months, the stock has lost-59.7% and faced a worst price of $2.63. Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer in the United States.
Has MACK Found The Bottom And Ready To Gain Momentum? Find Out Here
Galena Biopharma Inc (NASDAQ:GALE) settled 2.06% higher at $2.22 on below -normal volume of 1.69M shares during the last trading day. The stock has its 12-month high at $3 and 52-week low price was $1.23. It traded in a range of $2.15 to $2.26 during the last trading day. Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing oncology treatments to address major unmet medical needs to advance cancer care. It is developing a pipeline of immunotherapy product candidates for the treatment of various cancers based on the E75 peptide.
Why Should Investors Buy GALE After the Recent Fall? Just Go Here and Find Out
In the last trading session, Andalay Solar Inc (OTCMKTS: WEST) was down on low volume, trading at a volume of 1.64M shares versus its average daily volume of 3.67 million shares. At $0.0272, the stock has attained market capitalization of $2.21 million. Andalay Solar, Inc. designs, manufactures, markets, and sells solar power systems and solar panels with integrated micro inverters in the United States and Canada. Its products are designed for use in solar power systems for residential and commercial rooftop customers.
Why Should Investors Buy WEST After the Recent Fall? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)